CN Patent
CN104926714B — 2‑氯‑n‑(4‑氯‑3‑(2‑吡啶基)苯基)‑4‑甲基砜苯基苯甲酰胺的制备方法
Assigned to Tianjin University · Expires 2017-07-28 · 9y expired
What this patent protects
本发明公开了2‑氯‑N‑(4‑氯‑3‑(2‑吡啶基)苯基)‑4‑甲基砜苯基苯甲酰胺(V)的制备方法,其反应式为: 本发明具有操作简单,反应原料以及反应试剂易得,产物取代基类型多样,收率较高等优点。
USPTO Abstract
本发明公开了2‑氯‑N‑(4‑氯‑3‑(2‑吡啶基)苯基)‑4‑甲基砜苯基苯甲酰胺(V)的制备方法,其反应式为: 本发明具有操作简单,反应原料以及反应试剂易得,产物取代基类型多样,收率较高等优点。
Drugs covered by this patent
- Erivedge (vismodegib) · Roche
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.